Media center
Пресс-релизы
COVID-19 outbreak: Alfasigma donates over 100.000 euros to Romanian Hospitals
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis
Alfasigma USA Acquires Zelnorm™
Alfasigma SpA – Corporate announcement
Alfasigma expands its footprint in the U.S. through the acquisition of Pamlab from Nestle health science
Alfasigma is born the new italian pharmaceutical entity with strong international presence